Cargando…

Cross-cultural adaptation and semantic validation of an instrument to identify palliative requirements in Portuguese

OBJECTIVE: To translate and make cross-cultural adaptation of NECPAL CCOMS-ICO(©) tool to Portuguese, and to analyze its semantic validity. METHODS: A methodological research about NECPAL CCOMS-ICO(©) tool cross-cultural adaptation, translated from Spanish into Portuguese and measurement of semantic...

Descripción completa

Detalles Bibliográficos
Autores principales: Santana, Marcella Tardeli Esteves Angioleti, Gómez-Batiste, Xavier, da Silva, Lucia Marta Giunta, de Gutiérrez, Maria Gaby Rivero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531898/
https://www.ncbi.nlm.nih.gov/pubmed/33053019
http://dx.doi.org/10.31744/einstein_journal/2020AO5539
Descripción
Sumario:OBJECTIVE: To translate and make cross-cultural adaptation of NECPAL CCOMS-ICO(©) tool to Portuguese, and to analyze its semantic validity. METHODS: A methodological research about NECPAL CCOMS-ICO(©) tool cross-cultural adaptation, translated from Spanish into Portuguese and measurement of semantic validity. The cross-cultural adaptation process was conducted according to Beaton recommendations, including translation, translation synthesis, back-translation, and analysis of semantic, idiomatic, conceptual, and cultural equivalence of translated and back-translated tool versions, resulting in a pre-final version, which was submitted to a pre-test (n=35). Contend Validity Index was calculated to analyze semantic validity. RESULTS: Cross-cultural adaptation process allowed us to prepare the final version of this tool, which was named NECPAL-BR. Collected data from pre-testing step enabled the analysis of semantic validity. The Content Validity Index observed at this step was 0.94. CONCLUSION: The semantic validity of the tool in its Portuguese version was confirmed; therefore, it may assist in screening chronic progressive disease patients, aiming to provide early palliative care. It may also be used to develop clinical and team performance indicators, and be employed as a care management tool designed to optimize resources.